Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Fenazinel Dihydrochloride, a N-methyl-D-aspartate (NMDA) receptor antagonist, is used potentially for the treatment of ischemic stroke.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | Fenazinel Dihydrochloride, a N-methyl-D-aspartate (NMDA) receptor antagonist, is used potentially for the treatment of ischemic stroke. |
Synonyms | SIPI5052, SIPI 5052, SIPI-5052 |
Molecular Weight | 424.36 |
Formula | C21H27Cl2N3O2 |
CAS No. | 685138-02-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Fenazinel Dihydrochloride 685138-02-7 SIPI5052 SIPI 5052 SIPI-5052 Fenazinel inhibitor inhibit